132 related articles for article (PubMed ID: 8359180)
1. Chlorpromazine in human scalp hair as an index of dosage history: comparison with simultaneously measured haloperidol.
Sato H; Uematsu T; Yamada K; Nakashima M
Eur J Clin Pharmacol; 1993; 44(5):439-44. PubMed ID: 8359180
[TBL] [Abstract][Full Text] [Related]
2. Human scalp hair as evidence of individual dosage history of haloperidol: a possible linkage of haloperidol excretion into hair with hair pigment.
Uematsu T; Sato R; Fujimori O; Nakashima M
Arch Dermatol Res; 1990; 282(2):120-5. PubMed ID: 2353827
[TBL] [Abstract][Full Text] [Related]
3. The measurement of haloperidol and reduced haloperidol in hair as an index of dosage history.
Matsuno H; Uematsu T; Nakashima M
Br J Clin Pharmacol; 1990 Feb; 29(2):187-94. PubMed ID: 2306410
[TBL] [Abstract][Full Text] [Related]
4. Human scalp hair as evidence of individual dosage history of haloperidol: method and retrospective study.
Uematsu T; Sato R; Suzuki K; Yamaguchi S; Nakashima M
Eur J Clin Pharmacol; 1989; 37(3):239-44. PubMed ID: 2612538
[TBL] [Abstract][Full Text] [Related]
5. Human scalp hair as evidence of individual dosage history of haloperidol: prospective study.
Sato R; Uematsu T; Sato R; Yamaguchi S; Nakashima M
Ther Drug Monit; 1989 Nov; 11(6):686-91. PubMed ID: 2595750
[TBL] [Abstract][Full Text] [Related]
6. Possible effect of pigment on the pharmacokinetics of ofloxacin and its excretion in hair.
Uematsu T; Miyazawa N; Okazaki O; Nakashima M
J Pharm Sci; 1992 Jan; 81(1):45-8. PubMed ID: 1619568
[TBL] [Abstract][Full Text] [Related]
7. Analysis of nicotine content of hair for assessing individual cigarette-smoking behavior.
Mizuno A; Uematsu T; Oshima A; Nakamura M; Nakashima M
Ther Drug Monit; 1993 Apr; 15(2):99-104. PubMed ID: 8503145
[TBL] [Abstract][Full Text] [Related]
8. Using ofloxacin as a time marker in hair analysis for monitoring the dosage history of haloperidol.
Nakano M; Uematsu T; Sato H; Kosuge K; Nishimoto M; Nakashima M
Eur J Clin Pharmacol; 1994; 47(2):195-202. PubMed ID: 7859809
[TBL] [Abstract][Full Text] [Related]
9. Steady-state pharmacokinetics of haloperidol and reduced haloperidol in schizophrenic patients: analysis of factors determining their concentrations in hair.
Uematsu T; Matsuno H; Sato H; Hirayama H; Hasegawa K; Nakashima M
J Pharm Sci; 1992 Oct; 81(10):1008-11. PubMed ID: 1432610
[TBL] [Abstract][Full Text] [Related]
10. Concentrations of chlorpromazine and two of its active metabolites in plasma and cerebrospinal fluid of psychotic patients treated with fixed drug doses.
Wode-Helgodt B; Alfredsson G
Psychopharmacology (Berl); 1981; 73(1):55-62. PubMed ID: 6785790
[TBL] [Abstract][Full Text] [Related]
11. Chlorpromazine distribution in hamsters and mice bearing transplantable melanoma.
Fairchild RG; Greenberg D; Watts KP; Packer S; Atkins HL; Som P; Hannon SJ; Brill AB; Fand I; McNally WP
Cancer Res; 1982 Feb; 42(2):556-62. PubMed ID: 7055803
[TBL] [Abstract][Full Text] [Related]
12. Human scalp hair as evidence of individual dosage history of haloperidol: longer-term follow-up study.
Uematsu T; Sato R
Ther Drug Monit; 1990 Nov; 12(6):582-3. PubMed ID: 2275006
[TBL] [Abstract][Full Text] [Related]
13. Measurement of flecainide in hair as an index of drug exposure.
Takiguchi Y; Ishihara R; Kato R; Kamihara S; Yokota M; Uematsu T
J Pharm Sci; 2001 Nov; 90(11):1891-6. PubMed ID: 11745746
[TBL] [Abstract][Full Text] [Related]
14. Ofloxacin as a reference marker in hair of various colors.
Wilkins DG; Mizuno A; Borges CR; Slawson MH; Rollins DE
J Anal Toxicol; 2003 Apr; 27(3):149-55. PubMed ID: 12731656
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of chlorpromazine and key metabolites.
Yeung PK; Hubbard JW; Korchinski ED; Midha KK
Eur J Clin Pharmacol; 1993; 45(6):563-9. PubMed ID: 8157044
[TBL] [Abstract][Full Text] [Related]
16. Analysis of a new fluoroquinolone derivative (Q-35) in human scalp hair as an index of drug exposure and as a time marker in hair.
Uematsu T; Ohsawa Y; Mizuno A; Nakashima M
Int J Legal Med; 1994; 106(5):237-43. PubMed ID: 8068569
[TBL] [Abstract][Full Text] [Related]
17. The measurement of haloperidol and reduced haloperidol in neonatal hair as an index of placental transfer of maternal haloperidol.
Uematsu T; Yamada K; Matsuno H; Nakashima M
Ther Drug Monit; 1991 Mar; 13(2):183-7. PubMed ID: 2053128
[TBL] [Abstract][Full Text] [Related]
18. Hair analysis of flecainide for assessing the individual drug-taking behavior.
Takiguchi Y; Ishihara R; Torii M; Kato R; Kamihara S; Uematsu T
Eur J Clin Pharmacol; 2002 May; 58(2):99-101. PubMed ID: 12012140
[TBL] [Abstract][Full Text] [Related]
19. [Establishment of a method to analyze drugs in the hair and its application for determining patient compliance].
Uematsu T
Nihon Yakurigaku Zasshi; 1992 Dec; 100(6):475-83. PubMed ID: 1483601
[TBL] [Abstract][Full Text] [Related]
20. The effect of hair color on the incorporation of codeine into human hair.
Rollins DE; Wilkins DG; Krueger GG; Augsburger MP; Mizuno A; O'Neal C; Borges CR; Slawson MH
J Anal Toxicol; 2003; 27(8):545-51. PubMed ID: 14670132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
